Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Myocardial Ischemia
|
0.200 |
Biomarker
|
disease |
RGD |
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
|
12371906 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
<i>Apc<sup>Min/+</sup></i> mice when infected with CR and <i>BLT1<sup>-/-</sup>;Apc<sup>Min/+</sup></i> mice, exhibited similar co-localization of p62 with LC3B and Dclk1 within the tumors.
|
31040926 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we showed that the expression levels of VHL and microtubule-associated protein 1 light chain 3B (MAP1LC3B, LC3B) were inversely correlated with various tumor grades of RCC tissues. pVHL was found to possess the LIR motif within a beta domain that interacted with MAP1LC3B and ubiquitinated it.
|
30902965 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
High levels of CC3 (CC3<sup>High</sup>) and LC3B (LC3B<sup>High</sup>) were detected in 38% and 35% of the 113 CRCs, respectively, but no or only a few p-MLKL-positive cells were observed in any of the tumors.
|
31097354 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
It suggests that miR-204 can be used as a tumor suppressor gene and LC3B expression level can be used as a potential molecular marker to guide the diagnosis and treatment of patients with ovarian cancer.
|
31384174 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, analysis of LC3B protein in clinical breast cancer specimens and tumor xenografts revealed significant association between high Runx2 and low LC3B protein levels.
|
28345763 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our in vitro experimental data was further confirmed in primary tumors developed in syngeneic mice, which also showed ROS-mediated LC3B enhancement along with reduced autophagosomes, integrin-β3 and focal adhesion kinase ultimately leading to the decreased tumor mass.
|
30224639 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We analyzed 394 tumor specimens (pre-treatment, post-treatment, and metastases) from 260 osteosarcoma patients by immunohistochemistry for cytoplasmic light chain 3B (LC3B)-positive puncta, sequestosome 1 (SQSTM1), high mobility group box 1 (HMGB1), and HSP27 expression.
|
29592877 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
LC3B expression on tumour was assessed by immunohistochemistry and evaluated for associations with clinicopathological variables.
|
29859041 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
It turned out that the higher expression of LC3A protein was associated with adenocarcinoma compared to squamous cell carcinoma of lung (<i>p</i> = 0.008), positive staining of LC3B was significantly related to tumor grade (<i>p</i> = 0.006), and the protein expression of Beclin-1 was significantly correlated to pN stage (<i>p</i> = 0.041).
|
29545906 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In addition, a positive correlation was observed between loc146880 expression and lc3b levels in tumor tissues and serum of lung cancer patients.
|
27836757 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Analysis of tumor tissues showed increased levels of LC3B in AAE treated tumors, indicating elevated autophagic tumor cell death in vivo in treated mice.
|
25945840 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, LC3B may be a marker of tumor hypoxia and/or metastasis in EOC cells.
|
25607473 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Subgroup analyses revealed that within patients with poor-prognosis BC, HMGB1(+) LC3B(+) double-positive tumors had a better prognosis than BC that lacked one or both of these markers.
|
26506894 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
FDG PET tumour dimensions before therapy were correlated with LC3B expression (P=0.005).
|
24722179 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This may be explained by the fact that miR-204-5p increases in colorectal cancer cases in order to inhibit increased activity of LC3B-II in autophagy and Bcl2 against apoptosis posttranscriptionally and to take role as tumor suppressor.
|
25209181 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The LC3B density was similar between the peripheral and central area of the tumors (P = 0.328) but was significantly lower in the extratumoral area (P < 0.001 and P < 0.001, respectively).
|
24141623 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
AE also had anti-proliferative effects and induced the expression of the autophagic proteins beclin1 and LC3B-II in mouse xenograft tumors.
|
24133573 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In particular, expression of LC3A, LC3B and beclin-1 was highest in TNBC tumour cells, whereas that of LC3A and LC3B in the tumour stroma was lowest in TNBC.
|
23134379 |
2013 |